دورية أكاديمية

Results of the first phase 1 clinical trial of the HER-2/neu peptide (GP2) vaccine in disease-free breast cancer patients: united States Military Cancer Institute Clinical Trials Group Study I-04.

التفاصيل البيبلوغرافية
العنوان: Results of the first phase 1 clinical trial of the HER-2/neu peptide (GP2) vaccine in disease-free breast cancer patients: united States Military Cancer Institute Clinical Trials Group Study I-04.
المؤلفون: Carmichael MG, Benavides LC, Holmes JP, Gates JD, Mittendorf EA, Ponniah S, Peoples GE
المصدر: Cancer (0008543X); 1/15/2010, Vol. 116 Issue 2, p292-301, 10p
قاعدة البيانات: Complementary Index
الوصف
تدمد:0008543X
DOI:10.1002/cncr.24756